OVID   $1.22  4.27% Market Closed After Close 1.24 1.64%

Ovid Therapeutics Inc
Total Cash 76.97M
totalCashPerShare 1.085
EBITDA -65.78M
Total Debt 15.39M
quickRatio 5.452
currentRatio 5.729
Total Revenue 567.70K
debtToEquity 17.311
Revenue/Share 0.008
ROA -0.32612
ROE -0.29806998
grossProfits
freeCashflow -27.55M
operatingCashflow -52.90M
earningsGrowth
revenueGrowth 1.253
grossMargins 1.0
ebitdaMargins 0.0
operatingMargins -110.75149
profitMargins 0.0
enterpriseValue 20.03M
forwardPE -3.0076923
floatShares 46.49M
sharesOutstanding 70.97M
sharesShort 633.88K
sharesShortPriorMonth 721.30K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.16%
heldPercentInstitutions 0.57%
Short Ratio help_outline 4.10%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 1.253
Price To Book help_outline 0.94
earningsQuarterlyGrowth
netIncomeToCommon -29.75M
trailingEps -0.41%
forwardEps -0.39%
enterpriseToEbitda -0.30
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.2 3Q 2024
institutionsCount 108
lastUpdated Oct. 16, 2024, 6:56 p.m.